Line 59: | Line 59: | ||
<hr> | <hr> | ||
<h2>Achievements</h2> | <h2>Achievements</h2> | ||
− | <p>In this part of the EncaBcillus project, we successfully created and evaluated a novel completely heterologous biosensor for Beta-lactam antibiotics in <i>Bacillus subtilis</i>. This biosensor is able to detect the following Beta-Lactam antibiotics: ampicillin, carbenicillin, cefperazone, cefalexin. cefoxitin and penicillin G in liquid and on solid MH-Medium. Besides the detection range, we analyzed the sensitivity of the biosensor for these specific compounds in several dose-response experiments shown in Figure | + | <p>In this part of the EncaBcillus project, we successfully created and evaluated a novel completely heterologous biosensor for Beta-lactam antibiotics in <i>Bacillus subtilis</i>. This biosensor is able to detect the following Beta-Lactam antibiotics: ampicillin, carbenicillin, cefperazone, cefalexin. cefoxitin and penicillin G in liquid and on solid MH-Medium. Besides the detection range, we analyzed the sensitivity of the biosensor for these specific compounds in several dose-response experiments shown in Figure 4. Furthermore, we demonstrated the applicability of the biosensor when encapsulated into Peptidosomes. As depicted in Figure 5, the biosensor was able to sense the beta-lactam diffusing through the membrane of the Peptidosome. Hereby, we proved the possibility of encapsulating functional engineered bacteria into Peptidosomes. |
<p></p> | <p></p> | ||
<div style="display: flex; align-items: flex-start; flex-wrap: wrap;"> | <div style="display: flex; align-items: flex-start; flex-wrap: wrap;"> | ||
Line 65: | Line 65: | ||
<figure class="makeresponsive" style="padding-left:10%; padding-right:10%;"> | <figure class="makeresponsive" style="padding-left:10%; padding-right:10%;"> | ||
<img src="https://static.igem.org/mediawiki/2017/6/65/T--TU_Dresden--P_Biosensor_Figure9.png" | <img src="https://static.igem.org/mediawiki/2017/6/65/T--TU_Dresden--P_Biosensor_Figure9.png" | ||
− | alt="Figure | + | alt="Figure 4: Dose-Response Curves of the Biosensor"class="makeresponsive zoom"> |
− | <figcaption><b>Figure | + | <figcaption><b>Figure 4: Dose-Response Curves of the six different beta-Lactam antibiotics of biosensor 2</b> Observed luminescence signal (two hours after antibiotic exposure) was plotted according to each tested antibiotic concentration. Please note both axes are depicted logarithmic. Mean values and standard deviation are depicted from at least three biological replicates. |
</figcaption> | </figcaption> | ||
</figure> | </figure> | ||
Line 73: | Line 73: | ||
<figure class="makeresponsive floatleft" style="padding-left:10%; padding-right:10%;"> | <figure class="makeresponsive floatleft" style="padding-left:10%; padding-right:10%;"> | ||
<img src="https://static.igem.org/mediawiki/2017/9/90/T--TU_Dresden--P_Biosensor_Figure10.png" | <img src="https://static.igem.org/mediawiki/2017/9/90/T--TU_Dresden--P_Biosensor_Figure10.png" | ||
− | alt=" Figure | + | alt=" Figure 5: Encapsulation of the biosensor into Peptidosomes" |
class="makeresponsive zoom"> | class="makeresponsive zoom"> | ||
− | <figcaption><b>Figure | + | <figcaption><b>Figure 5: Encapsulation Experiment with Biosensor 1.</b>The pictures in the upper row show the distribution of the Peptidosomes at the time point of luminescence detection. The plate layout is defined in the legend beneath the photographs. Pink arrows indicate Peptidosomes with a luminescence signal due to the encapsulated biosensor. Upper row of well plate: non-induced samples. Lower row of well plate: induced with cefoperazone (0.2µg µl<sup>-1</sup>).</figcaption> |
</figure> | </figure> | ||
</div> | </div> | ||
Line 88: | Line 88: | ||
<h2>Achievements</h2> | <h2>Achievements</h2> | ||
<p>We evaluated and proved the applicability of a powerful toolbox to quickly screen via a high throughput procedure for improved secretion of proteins in bacteria - the Signal Peptide Toolbox. It combines combinatorial construction with highly reproducible, quantitative measurements to maximize secretion levels.</p> | <p>We evaluated and proved the applicability of a powerful toolbox to quickly screen via a high throughput procedure for improved secretion of proteins in bacteria - the Signal Peptide Toolbox. It combines combinatorial construction with highly reproducible, quantitative measurements to maximize secretion levels.</p> | ||
− | <p>We applied the Signal Peptide Toolbox to three different proteins. Via demonstrating the secretion of <i>sfGFP</i>, <i>amyE</i> and <i>mCherry</i>, and identifying the most potent SP-protein combinations for each of them (Figure | + | <p>We applied the Signal Peptide Toolbox to three different proteins. Via demonstrating the secretion of <i>sfGFP</i>, <i>amyE</i> and <i>mCherry</i>, and identifying the most potent SP-protein combinations for each of them (Figure 6, 7, 8), we proved the applicability of this powerful toolbox.</i> |
</p> | </p> | ||
<figure> | <figure> | ||
<figure class="makeresponsive floatright" style="width: 38.62%;"> | <figure class="makeresponsive floatright" style="width: 38.62%;"> | ||
<img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/f/f5/T--TU_Dresden--mCherry--screening2.png/800px-T--TU_Dresden--mCherry--screening2.png"> | <img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/f/f5/T--TU_Dresden--mCherry--screening2.png/800px-T--TU_Dresden--mCherry--screening2.png"> | ||
− | <figcaption><b>Figure | + | <figcaption><b>Figure 8: Sequenced signal peptides in front of <i><b>mCherry</b></i>.</b> Fold change in secretion efficiency (fluorescence) over wild type. Depicted candidates were identified by sequencing.</figcaption></figure> |
<figure class="makeresponsive floatright" style="width:36.63%;"> | <figure class="makeresponsive floatright" style="width:36.63%;"> | ||
− | <img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/3/32/YOURWORLDSHALLSUFFER.png/800px-YOURWORLDSHALLSUFFER.png"><figcaption><b>Figure | + | <img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/3/32/YOURWORLDSHALLSUFFER.png/800px-YOURWORLDSHALLSUFFER.png"><figcaption><b>Figure 7: Sequenced signal peptides in front of <i><b>amyE</b></i>.</b> Fold change in secretion efficiency (amylase activity) over wild type. Depicted candidates were identified by sequencing.</figcaption></figure> |
<figure class="makeresponsive floatleft" style="width: 24.75%;"> | <figure class="makeresponsive floatleft" style="width: 24.75%;"> | ||
<img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/3/37/T--TU_Dresden--secretion--tabaluga.png/766px-T--TU_Dresden--secretion--tabaluga.png"> | <img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/3/37/T--TU_Dresden--secretion--tabaluga.png/766px-T--TU_Dresden--secretion--tabaluga.png"> | ||
− | <figcaption><b>Figure | + | <figcaption><b>Figure 6: Sequenced signal peptides in front of <i><b>sfGFP</b></i>.</b> Fold change in secretion efficiency (fluorescence) over wild type. Depicted candidates were identified by sequencing.</figcaption> |
</figure> | </figure> | ||
</figure> | </figure> | ||
Line 111: | Line 111: | ||
<figure class="makeresponsive floatright" style="width: 42%;"> | <figure class="makeresponsive floatright" style="width: 42%;"> | ||
<img class="zoom" src="https://static.igem.org/mediawiki/2017/4/44/FrauDolor.png" class="makeresponsive"> | <img class="zoom" src="https://static.igem.org/mediawiki/2017/4/44/FrauDolor.png" class="makeresponsive"> | ||
− | <figcaption><b>Figure | + | <figcaption><b>Figure 10: Three color stages of the EV.</b> All agar plates shown contain X-Gal and IPTG. <b>A</b> The EV without any inserts. <b>B</b> The EV with an inserted SP and gene of interest. <b>C</b> The EV with RPFsyn2 and an inserted gene of interest.</figcaption> |
</figure> | </figure> | ||
<figure class="makeresponsive floatright" style="width: 31.2%;"> | <figure class="makeresponsive floatright" style="width: 31.2%;"> | ||
<img class="zoom" src="https://static.igem.org/mediawiki/2017/3/36/EvaluationVectorMap.png" alt="An example picture to show how to include them." class="makeresponsive"> | <img class="zoom" src="https://static.igem.org/mediawiki/2017/3/36/EvaluationVectorMap.png" alt="An example picture to show how to include them." class="makeresponsive"> | ||
− | <figcaption><b>Figure | + | <figcaption><b>Figure 9: Vector map of the EV.</b> The MCS is indicated in colors, grey elements refer to features necessary for cloning in <i>E. coli</I> and the white elements refer to <i>B. subtilis</i> specific vector parts.</figcaption> |
</figure> | </figure> | ||
− | <p>We build a unique multiple cloning site which allows for easy insertion of both, a promoter and two basic or composite parts - the Evaluation Vector. The distinct features of the Evaluation Vector provide an easy cloning and screening workflow (Figure | + | <p>We build a unique multiple cloning site which allows for easy insertion of both, a promoter and two basic or composite parts - the Evaluation Vector. The distinct features of the Evaluation Vector provide an easy cloning and screening workflow (Figure 9).</p> |
− | <p>Additionally, the insertion of reporters to identify positive replacements by insert integration allow for a quick cloning and screening procedure in <i>Escherichia coli</i>. All three different stages of the insertion of expression units can be identified via a three-color scheme easily (Figure | + | <p>Additionally, the insertion of reporters to identify positive replacements by insert integration allow for a quick cloning and screening procedure in <i>Escherichia coli</i>. All three different stages of the insertion of expression units can be identified via a three-color scheme easily (Figure 10).</p> |
<p>Furthermore, we proved the applicability and functionality of the Evaluation Vector as we evaluated it in the course of the Signal Peptide Toolbox.</p> | <p>Furthermore, we proved the applicability and functionality of the Evaluation Vector as we evaluated it in the course of the Signal Peptide Toolbox.</p> | ||
</figure> | </figure> |
Revision as of 14:48, 1 November 2017